NCT01663662View on ClinicalTrials.gov

The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Heart Failure
Interventions
DRUG

Tolvaptan

DRUG

placebo

Trial Locations (1)

48109

University of Michigan Health Systems, Ann Arbor

Sponsors

Collaborators (1)

Otsuka Pharmaceuticals
All Listed Sponsors
collaborator

Otsuka Pharmaceuticals

UNKNOWN

lead

University of Michigan

OTHER

NCT01663662 - The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study | Biotech Hunter | Biotech Hunter